Stay updated on LATITUDE Study: Daily Long-Acting Therapy Clinical Trial
Sign up to get notified when there's something new on the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page.

Latest updates to the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedPublications updated: added Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges (NEJM 2026 Feb 26) and removed the earlier NEJM Online ahead of print entry (Feb 18, 2026).SummaryDifference0.0%

- Check31 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision: v3.4.3 is now listed, replacing v3.4.2.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a publication citation to the Publications section: Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges, N Engl J Med. 2026 Feb 18 (online ahead of print).SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.4.2 was added, and the government funding lapse notice was removed. These updates do not affect the study details, eligibility criteria, or locations.SummaryDifference0.3%

Stay in the know with updates to LATITUDE Study: Daily Long-Acting Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LATITUDE Study: Daily Long-Acting Therapy Clinical Trial page.